Conjunts de dades de producció científica> Bioquímica i Biotecnologia

Baseline characteristics of participants completing 1-year intervention.A

  • Identification data

    Identifier: PC:4085
    Handle: https://hdl.handle.net/20.500.11797/PC4085
    Authors:
    Salas-Salvadó, Jordi
    Abstract:
    MetS, Metabolic Syndrome; BMI, body mass index; CHD, coronary heart disease; WC, waist circumference; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; BP, blood pressure. A. Values are expressed as mean ± SD or percentage of participants. B. p value for comparison between groups calculated by one-factor ANOVA for continuous variables or χ2 test for categorical variables. C. BMI≥25 kg/m2. D. Systolic BP≥140 mmHg or diastolic BP≥90 mmHg or antihypertensive medication. E. LDL cholesterol ≥160 mg/dL or lipid-lowering therapy; HDL cholesterol ≤40 mg/dL in men or ≤50 mg/dL in women. F. Definite myocardial infarction or sudden death before 55 years in male first-degree relatives or before 65 years in female first-degree relatives. G. The metabolic syndrome components are defined according to the IDF, NHLBI, AHA, WHF, IAC, and IASO recent criteria.

  • Others:

    Subject matter: Biologia
    Access rights: info:eu-repo/semantics/openAccess
    Researcher identifier: 0000-0003-2700-7459
    Published by (editorial): Universitat Rovira i Virgili (URV)
    Related publications: Mayneris-Perxachs, J., Sala-Vila, A., Chisaguano, M., Castellote, A. I., Estruch, R., Covas, M. I., Fitó, M., Salas-Salvadó, J., Martínez-González, M. A., Lamuela-Raventós, R., Ros, E., López-Sabater, M. C., & for PREDIMED Study Investigators. (2014). Effects of 1-year intervention with a mediterranean diet on plasma fatty acid composition and metabolic syndrome in a population at high cardiovascular risk. PLoS ONE, 9(3), e85202. https://doi.org/10.1371/journal.pone.0085202
    Abstract: MetS, Metabolic Syndrome; BMI, body mass index; CHD, coronary heart disease; WC, waist circumference; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; BP, blood pressure. A. Values are expressed as mean ± SD or percentage of participants. B. p value for comparison between groups calculated by one-factor ANOVA for continuous variables or χ2 test for categorical variables. C. BMI≥25 kg/m2. D. Systolic BP≥140 mmHg or diastolic BP≥90 mmHg or antihypertensive medication. E. LDL cholesterol ≥160 mg/dL or lipid-lowering therapy; HDL cholesterol ≤40 mg/dL in men or ≤50 mg/dL in women. F. Definite myocardial infarction or sudden death before 55 years in male first-degree relatives or before 65 years in female first-degree relatives. G. The metabolic syndrome components are defined according to the IDF, NHLBI, AHA, WHF, IAC, and IASO recent criteria.
    Departament: Bioquímica i Biotecnologia
    DOI: 10.1371/journal.pone.0085202.t001
    Document type: info:eu-repo/semantics/other
    Related publication's DOI: Baseline characteristics of participants completing 1-year intervention.A
    Repository ingest date: 2014-03-20
    Author: Salas-Salvadó, Jordi
    Keywords: Biochemistry, lipids, Fatty acids, Lipid metabolism, metabolism, nutrition, cardiology, Cardiovascular, harmacology, Clinical medicine, clinical trials, epidemiology, Biomarker epidemiology, Cardiovascular disease epidemiology, Environmental epidemiology, Metabolic disorders, Public and occupational health, Behavioral and social aspects of health, research design, Clinical research design, completing, 1-year
    Research group: Alimentación, Nutrición, Crecimiento y Salud Mental
    Dataset publication year: 2014
    Dataset title: Baseline characteristics of participants completing 1-year intervention.A

  • Keywords:

    Biologia
    Biochemistry, lipids, Fatty acids, Lipid metabolism, metabolism, nutrition, cardiology, Cardiovascular, harmacology, Clinical medicine, clinical trials, epidemiology, Biomarker epidemiology, Cardiovascular disease epidemiology, Environmental epidemiology, Metabolic disorders, Public and occupational health, Behavioral and social aspects of health, research design, Clinical research design, completing, 1-year

  • Documents:

  • Cerca a google

    Search to google scholar